Background and Aims: Previously we have demonstrated that conjugated linoleic acid (CLA) is a pro-resolving lipid mediator that induces regression of atherosclerosis in vivo via modulation of monocyte/macrophage function. microRNA-155 is a key regulator of inflammation and is induced by pro-inflammatory stimuli. miR-155 has been demonstrated to mediate pro-atherogenic effects and miR-155 deficiency in murine models is associated with reduced atherosclerotic lesion burden. Aim: To investigate the effects of CLA on miR-155 and and the downstream target, SHIP-1. To investigate the role of miR-155 on the lesion microenvironment in human plaques.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Published online: August 03, 2019EAS19-0754
© 2019 Published by Elsevier Inc.